FindTrial
Sign In

The randomized controlled study for special acupoints focused extracorporeal shockwave treatment as adjuvant treatment of moderate to severe cancer pain

The randomized controlled study for special acupoints focused extracorporeal shockwave treatment as adjuvant treatment of moderate to severe cancer pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022229
Enrollment
Unknown
Registered
2019-03-31
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Control Group:standardized three ladder oral pain medication+no-output Special Acupoints Focused Extracorporeal Shockwave Stimulation
Treatment Group:standardized three ladder oral pain medication+Special Acupoints Focused Extracorporeal Shockwave Stimulation

Sponsors

Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 80 years, diagnosed with cancer; NRS score = 4; Expected survival = 1 month; Normal intelligence, can cooperate with pain assessment and questionnaire.

Exclusion criteria

Exclusion criteria: Combined with non-cancer related pain; vital organ failure;Pregnant or lactating women; brain metastasis; Those who undergoing chemoradiotherapy; Unable to take medicine regularly.

Design outcomes

Primary

MeasureTime frame
NRS score;Living quality evaluation;analgesic onset time;—

Secondary

MeasureTime frame
depression;—

Countries

China

Contacts

Public ContactYan Min
zryanmin@zju.edu.cn+86 13757118632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026